A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis
- PMID: 24256812
- PMCID: PMC3959809
- DOI: 10.1093/hmg/ddt587
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis
Abstract
Identification of mutations at familial loci for amyotrophic lateral sclerosis (ALS) has provided novel insights into the aetiology of this rapidly progressing fatal neurodegenerative disease. However, genome-wide association studies (GWAS) of the more common (∼90%) sporadic form have been less successful with the exception of the replicated locus at 9p21.2. To identify new loci associated with disease susceptibility, we have established the largest association study in ALS to date and undertaken a GWAS meta-analytical study combining 3959 newly genotyped Italian individuals (1982 cases and 1977 controls) collected by SLAGEN (Italian Consortium for the Genetics of ALS) together with samples from Netherlands, USA, UK, Sweden, Belgium, France, Ireland and Italy collected by ALSGEN (the International Consortium on Amyotrophic Lateral Sclerosis Genetics). We analysed a total of 13 225 individuals, 6100 cases and 7125 controls for almost 7 million single-nucleotide polymorphisms (SNPs). We identified a novel locus with genome-wide significance at 17q11.2 (rs34517613 with P = 1.11 × 10(-8); OR 0.82) that was validated when combined with genotype data from a replication cohort (P = 8.62 × 10(-9); OR 0.833) of 4656 individuals. Furthermore, we confirmed the previously reported association at 9p21.2 (rs3849943 with P = 7.69 × 10(-9); OR 1.16). Finally, we estimated the contribution of common variation to heritability of sporadic ALS as ∼12% using a linear mixed model accounting for all SNPs. Our results provide an insight into the genetic structure of sporadic ALS, confirming that common variation contributes to risk and that sufficiently powered studies can identify novel susceptibility loci.
Figures



Similar articles
-
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.Lancet Neurol. 2010 Oct;9(10):986-94. doi: 10.1016/S1474-4422(10)70197-6. Lancet Neurol. 2010. PMID: 20801717 Free PMC article.
-
Replication analysis of genetic variants on 17q11.2 and 9p21.2 with sporadic amyotrophic lateral sclerosis and Parkinson's disease in a Chinese population.Neurobiol Aging. 2015 Nov;36(11):3116.e1-3116.e3. doi: 10.1016/j.neurobiolaging.2015.07.026. Epub 2015 Aug 1. Neurobiol Aging. 2015. PMID: 26304631
-
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.Neurobiol Aging. 2013 Jan;34(1):357.e7-19. doi: 10.1016/j.neurobiolaging.2012.07.017. Epub 2012 Sep 5. Neurobiol Aging. 2013. PMID: 22959728 Free PMC article.
-
[Personal genome analysis in amyotrophic lateral sclerosis].Brain Nerve. 2013 Mar;65(3):257-65. Brain Nerve. 2013. PMID: 23475517 Review. Japanese.
-
Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.Neuroepidemiology. 2021;55(5):342-353. doi: 10.1159/000516752. Epub 2021 Jul 9. Neuroepidemiology. 2021. PMID: 34247168 Review.
Cited by
-
Abnormal Brain Protein Abundance and Cross-tissue mRNA Expression in Amyotrophic Lateral Sclerosis.Mol Neurobiol. 2024 Jan;61(1):510-518. doi: 10.1007/s12035-023-03587-2. Epub 2023 Aug 28. Mol Neurobiol. 2024. PMID: 37639066 Free PMC article.
-
A qualitative analysis of the attitudes of Irish patients towards participation in genetic-based research.Ir J Med Sci. 2016 Nov;185(4):825-831. doi: 10.1007/s11845-015-1373-7. Epub 2015 Oct 23. Ir J Med Sci. 2016. PMID: 26499982
-
Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration.Hum Mol Genet. 2017 Nov 1;26(21):4153-4167. doi: 10.1093/hmg/ddx304. Hum Mol Genet. 2017. PMID: 28973139 Free PMC article.
-
SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides.Neurobiol Dis. 2025 Sep;213:106986. doi: 10.1016/j.nbd.2025.106986. Epub 2025 Jun 3. Neurobiol Dis. 2025. PMID: 40473123 Free PMC article.
-
Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis.Hum Mol Genet. 2018 Nov 1;27(21):3761-3771. doi: 10.1093/hmg/ddy260. Hum Mol Genet. 2018. PMID: 30010873 Free PMC article.
References
-
- Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031–2041. - PubMed
-
- Beghi E., Logroscino G., Chiò A., Hardiman O., Mitchell D., Swingler R., Traynor B.J. EURALS Consortium. The epidemiology of ALS and the role of population-based registries. Biochim. Biophys. Acta. 2006;1762:1150–1157. - PubMed
-
- Armon C. An evidence based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22:217–228. - PubMed
-
- van Es M.A., van Vught P.W., Blauw H.M., Franke L., Saris C.G., Van den Bosch L., de Jong S.W., de Jong V., Baas F., van't Slot R., et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2007;40:29–31. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- MR/K013041/1/MRC_/Medical Research Council/United Kingdom
- 089701/WT_/Wellcome Trust/United Kingdom
- G0900635/MRC_/Medical Research Council/United Kingdom
- MR/L501529/1/MRC_/Medical Research Council/United Kingdom
- RC2 NS070342/NS/NINDS NIH HHS/United States
- MR/J006742/1/MRC_/Medical Research Council/United Kingdom
- G0902227/MRC_/Medical Research Council/United Kingdom
- G0900688/MRC_/Medical Research Council/United Kingdom
- R01 NS050557/NS/NINDS NIH HHS/United States
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- 1R01NS073873/NS/NINDS NIH HHS/United States
- G0701420/MRC_/Medical Research Council/United Kingdom
- MC_G1000733/MRC_/Medical Research Council/United Kingdom
- MR/K01417X/1/MRC_/Medical Research Council/United Kingdom
- R01 NS073873/NS/NINDS NIH HHS/United States
- MR/L501517/1/MRC_/Medical Research Council/United Kingdom
- G1100695/MRC_/Medical Research Council/United Kingdom
- G0501573/MRC_/Medical Research Council/United Kingdom
- G0500289/MRC_/Medical Research Council/United Kingdom
- G0600974/MRC_/Medical Research Council/United Kingdom
- 070122/A/02/Z/WT_/Wellcome Trust/United Kingdom
- RC2-NS070-342/NS/NINDS NIH HHS/United States
- GTB12001/TI_/Telethon/Italy
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous